|
WO2013074916A1
(en)
*
|
2011-11-18 |
2013-05-23 |
Board Of Regents, The University Of Texas System |
Car+ t cells genetically modified to eliminate expression of t- cell receptor and/or hla
|
|
KR101763499B1
(ko)
|
2012-11-07 |
2017-07-31 |
화이자 인코포레이티드 |
항-il-13 수용체 알파 2 항체 및 항체-약물 접합체
|
|
US20150037304A1
(en)
*
|
2013-03-12 |
2015-02-05 |
Sangamo Biosciences, Inc. |
Methods and compositions for modification of hla
|
|
EP3673732A3
(en)
*
|
2015-10-27 |
2020-07-29 |
Recombinetics, Inc. |
Engineering of humanized car t-cells and platelets by genetic complementation
|
|
WO2017093969A1
(en)
*
|
2015-12-04 |
2017-06-08 |
Novartis Ag |
Compositions and methods for immunooncology
|
|
US12083148B2
(en)
*
|
2017-02-22 |
2024-09-10 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
IL13Ra2-binding chimeric antigen receptors
|
|
WO2019006072A1
(en)
*
|
2017-06-30 |
2019-01-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
CHIMERIC ANTIGENIC RECEPTORS TO ANTIGEN OF MATURATION OF LYMPHOCYTES B WITH HUMAN DOMAINS
|
|
WO2019014581A1
(en)
*
|
2017-07-14 |
2019-01-17 |
The Broad Institute, Inc. |
METHODS AND COMPOSITIONS FOR MODULATING THE ACTIVITY OF A CYTOTOXIC LYMPHOCYTE
|
|
CN109456943A
(zh)
*
|
2017-09-06 |
2019-03-12 |
亘喜生物科技(上海)有限公司 |
通用型嵌合抗原受体t细胞制备技术
|
|
CN107723275B
(zh)
*
|
2017-10-20 |
2020-09-04 |
重庆精准生物技术有限公司 |
通用型car-t细胞及其制备方法和应用
|
|
WO2019126774A1
(en)
*
|
2017-12-22 |
2019-06-27 |
The Broad Institute, Inc. |
Novel crispr enzymes and systems
|
|
JP7438123B2
(ja)
*
|
2018-03-14 |
2024-02-26 |
シアトル チルドレンズ ホスピタル (ディービーエイ シアトル チルドレンズ リサーチ インスティテュート) |
腫瘍特異的T細胞免疫療法用のIL-13受容体α2(IL13Rα2)標的キメラ抗原受容体
|
|
EP3824075A4
(en)
*
|
2018-07-17 |
2022-04-20 |
The Regents of The University of California |
CHIMERA ANTIGEN RECEPTOR T-CELLS DERIVED FROM IMMUNOMANIPULATED PLURIPOTENTS STEM CELLS
|
|
EP4003407A1
(en)
*
|
2019-07-23 |
2022-06-01 |
Mnemo Therapeutics |
Immune cells defective for suv39h1
|
|
US20210128617A1
(en)
*
|
2019-08-27 |
2021-05-06 |
The Trustees Of The University Of Pennsylvania |
SYNTHETIC CARS TO TREAT IL13R-alpha-2 POSITIVE HUMAN AND CANINE TUMORS
|
|
JP7670358B2
(ja)
*
|
2020-01-02 |
2025-04-30 |
寧波茂行生物医薬科技有限公司 |
修飾された免疫エフェクター細胞及びその調製方法
|
|
US11965022B2
(en)
*
|
2020-12-31 |
2024-04-23 |
Sana Biotechnology, Inc. |
Methods and compositions for modulating CAR-T activity
|
|
AU2022301099A1
(en)
*
|
2021-07-01 |
2024-02-15 |
Ningbo T-Maximum Biopharmaceuticals Co., Ltd. |
Antigen-binding polypeptide targeting b7h3 and application thereof
|
|
JP2024527537A
(ja)
*
|
2021-07-01 |
2024-07-25 |
寧波茂行生物医薬科技有限公司 |
Gd2を標的とするユニバーサルcar-t細胞及びその製造方法並びに使用
|